Advanced and Metastatic Cancer Patients With Tumors Harboring FGF/FGFR Tumors

specific

A pancreatic neuroendocrine tumor that has spread extensively to other anatomic sites or is no longer responding to treatment.

18

Centers

0

Active Trials

—

Cancer Funding

Top Centers for Advanced and Metastatic Cancer Patients With Tumors Harboring FGF/FGFR Tumors(18)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
UCSF Helen Diller Family Comprehensive Cancer CenterSan Francisco, CA
NCI Comprehensive
52.8
2
Dana-Farber Cancer InstituteBoston, MA
NCI Comprehensive
52.8
3
Mayo Clinic Comprehensive Cancer CenterRochester, MN
NCI Comprehensive
52.8
4
The University of Texas MD Anderson Cancer CenterHouston, TX
NCI Comprehensive
52.8
5
City of Hope Comprehensive Cancer CenterDuarte, CA
NCI Comprehensive
52.8
6
Huntsman Cancer Institute at the University of UtahSalt Lake City, UT
NCI Comprehensive
52.8
7
Roswell Park Comprehensive Cancer CenterBuffalo, NY
NCI Comprehensive
52.8
8
University of Virginia Cancer CenterCharlottesville, VA
NCI Comprehensive
52.8
9
The University of Arizona Cancer CenterTucson, AZ
NCI Comprehensive
52.8
10
Medical College of Wisconsin Cancer CenterMilwaukee, WI
52.8
11
Sidney Kimmel Comprehensive Cancer Center at JeffersonPhiladelphia, PA
NCI Comprehensive
52.8
12
The University of Kansas Cancer CenterKansas City, KS
NCI Comprehensive
52.8
13
University of Illinois Cancer CenterChicago, IL
52.8
14
University of New Mexico Comprehensive Cancer CenterAlbuquerque, NM
NCI Comprehensive
52.8
15
Boston University Cancer CenterBoston, MA
52.8
16
Karmanos Cancer InstituteDetroit, MI
NCI Comprehensive
52.8
17
Cancer Center at IllinoisUrbana, IL
52.8
18
Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ
52.8

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →